Similarly, the increase in the expression of TRIM21 triggered by high-glucose exposure was not affected by diabetes-related AGEs and ROS, as demonstrated through the use of the inhibitors FPS-ZM1 (RAGE) and setanaxib (ROS) (Supplementary Fig. 3K, L). Here, TRIM21 is linked to diabetes mellitus.